Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Clinical and genetic variability of PAX2-related disorder in the Japanese population.

Rossanti R, Morisada N, Nozu K, Kamei K, Horinouchi T, Yamamura T, Minamikawa S, Fujimura J, Nagano C, Sakakibara N, Ninchoji T, Kaito H, Ito S, Tanaka R, Iijima K.

J Hum Genet. 2020 Mar 16. doi: 10.1038/s10038-020-0741-y. [Epub ahead of print]

PMID:
32203253
2.

Crescentic IgA nephropathy in children.

Shima Y, Nakanishi K, Hama T, Mukaiyama H, Sato M, Tanaka Y, Tanaka R, Kaito H, Nozu K, Sako M, Iijima K, Yoshikawa N.

Pediatr Nephrol. 2020 Jan 28. doi: 10.1007/s00467-020-04483-w. [Epub ahead of print]

PMID:
31993782
3.

Molecular mechanisms determining severity in patients with Pierson syndrome.

Minamikawa S, Miwa S, Inagaki T, Nishiyama K, Kaito H, Ninchoji T, Yamamura T, Nagano C, Sakakibara N, Ishimori S, Hara S, Yoshikawa N, Hirano D, Harada R, Hamada R, Matsunoshita N, Nagata M, Shima Y, Nakanishi K, Nagase H, Takeda H, Morisada N, Iijima K, Nozu K.

J Hum Genet. 2020 Apr;65(4):355-362. doi: 10.1038/s10038-019-0715-0. Epub 2020 Jan 21.

PMID:
31959872
4.

Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Nagano C, Sakakibara N, Nakanishi K, Shima Y, Morisada N, Ishiko S, Aoto Y, Nagase H, Takeda H, Rossanti R, Kaito H, Matsuo M, Iijima K.

Sci Rep. 2019 Sep 3;9(1):12696. doi: 10.1038/s41598-019-48990-9.

5.

Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome.

Yamamura T, Nozu K, Minamikawa S, Horinouchi T, Sakakibara N, Nagano C, Aoto Y, Ishiko S, Nakanishi K, Shima Y, Nagase H, Rossanti R, Ye MJ, Nozu Y, Ishimori S, Morisada N, Kaito H, Iijima K.

Mol Genet Genomic Med. 2019 Sep;7(9):e883. doi: 10.1002/mgg3.883. Epub 2019 Jul 30.

6.

Molecular assay for an intronic variant in NUP93 that causes steroid resistant nephrotic syndrome.

Rossanti R, Shono A, Miura K, Hattori M, Yamamura T, Nakanishi K, Minamikawa S, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Kaito H, Nagase H, Morisada N, Asanuma K, Matsuo M, Nozu K, Iijima K.

J Hum Genet. 2019 Jul;64(7):673-679. doi: 10.1038/s10038-019-0606-4. Epub 2019 Apr 23.

PMID:
31015583
7.

Renal-hepatic-pancreatic dysplasia-1 diagnosed on comprehensive gene analysis.

Inaguma Y, Kaito H, Morisada N, Iijima K, Tanaka R.

Pediatr Int. 2019 Feb;61(2):210-212. doi: 10.1111/ped.13758. Epub 2019 Feb 7. No abstract available.

PMID:
30734414
8.

Clinical and Genetic Characteristics in Patients With Gitelman Syndrome.

Fujimura J, Nozu K, Yamamura T, Minamikawa S, Nakanishi K, Horinouchi T, Nagano C, Sakakibara N, Nakanishi K, Shima Y, Miyako K, Nozu Y, Morisada N, Nagase H, Ninchoji T, Kaito H, Iijima K.

Kidney Int Rep. 2018 Sep 28;4(1):119-125. doi: 10.1016/j.ekir.2018.09.015. eCollection 2019 Jan.

9.

Pair analysis and custom array CGH can detect a small copy number variation in COQ6 gene.

Nakanishi K, Okamoto T, Nozu K, Hara S, Sato Y, Hayashi A, Takahashi T, Nagano C, Sakakibara N, Horinouchi T, Fujimura J, Minamikawa S, Yamamura T, Rossanti R, Nagase H, Kaito H, Ariga T, Iijima K.

Clin Exp Nephrol. 2019 May;23(5):669-675. doi: 10.1007/s10157-018-1682-z. Epub 2018 Dec 24.

PMID:
30584653
10.

The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.

Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.

Sci Rep. 2018 Nov 23;8(1):17322. doi: 10.1038/s41598-018-35798-2.

11.

Three Severe Cases of Viral Infections with Post-Kidney Transplantation Successfully Confirmed by Polymerase Chain Reaction and Flow Cytometry.

Nakanishi K, Kaito H, Ogi M, Takai D, Fujimura J, Horinouchi T, Yamamura T, Minamikawa S, Ninchoji T, Nozu K, Imadome KI, Iijima K.

Case Rep Nephrol Dial. 2018 Sep 25;8(3):198-206. doi: 10.1159/000493092. eCollection 2018 Sep-Dec.

12.

Clinicopathological characteristics and renal outcomes of childhood-onset lupus nephritis with acute kidney injury: A multicenter study.

Ishimori S, Kaito H, Shima Y, Kamioka I, Hamahira K, Nozu K, Nakanishi K, Tanaka R, Yoshikawa N, Iijima K.

Mod Rheumatol. 2019 Nov;29(6):970-976. doi: 10.1080/14397595.2018.1532861. Epub 2018 Dec 18.

PMID:
30289013
13.

Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC).

Pediatr Nephrol. 2019 May;34(5):837-846. doi: 10.1007/s00467-018-4099-8. Epub 2018 Oct 3.

PMID:
30284023
14.

A review of clinical characteristics and genetic backgrounds in Alport syndrome.

Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, Kaito H, Kanemoto K, Kobayashi A, Tanaka E, Tanaka K, Hama T, Fujimaru R, Miwa S, Yamamura T, Yamamura N, Horinouchi T, Minamikawa S, Nagata M, Iijima K.

Clin Exp Nephrol. 2019 Feb;23(2):158-168. doi: 10.1007/s10157-018-1629-4. Epub 2018 Aug 20. Review.

15.

Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.

Umehara H, Maekawa Y, Koizumi F, Shimizu M, Ota T, Fouad TM, Willey J, Kaito H, Shiraishi N, Nakashima D, Akinaga S, Ueno NT.

Ther Adv Med Oncol. 2018 Jul 30;10:1758835918786858. doi: 10.1177/1758835918786858. eCollection 2018.

16.

Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Omori T, Nakanishi K, Fujimura J, Ashida A, Kitamura M, Kawano M, Shimabukuro W, Kitabayashi C, Imafuku A, Tamagaki K, Kamei K, Okamoto K, Fujinaga S, Oka M, Igarashi T, Miyazono A, Sawanobori E, Fujimaru R, Nakanishi K, Shima Y, Matsuo M, Ye MJ, Nozu Y, Morisada N, Kaito H, Iijima K.

J Am Soc Nephrol. 2018 Aug;29(8):2244-2254. doi: 10.1681/ASN.2018030228. Epub 2018 Jun 29.

17.

Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity.

Roche FP, Pietilä I, Kaito H, Sjöström EO, Sobotzki N, Noguer O, Skare TP, Essand M, Wollscheid B, Welsh M, Claesson-Welsh L.

Mol Cancer Ther. 2018 Sep;17(9):1961-1972. doi: 10.1158/1535-7163.MCT-18-0097. Epub 2018 Jun 26.

18.

Congenital chloride diarrhea needs to be distinguished from Bartter and Gitelman syndrome.

Matsunoshita N, Nozu K, Yoshikane M, Kawaguchi A, Fujita N, Morisada N, Ishimori S, Yamamura T, Minamikawa S, Horinouchi T, Nakanishi K, Fujimura J, Ninchoji T, Morioka I, Nagase H, Taniguchi-Ikeda M, Kaito H, Iijima K.

J Hum Genet. 2018 Jul;63(8):887-892. doi: 10.1038/s10038-018-0470-7. Epub 2018 May 30.

PMID:
29849040
19.

Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment.

Ashraf S, Kudo H, Rao J, Kikuchi A, Widmeier E, Lawson JA, Tan W, Hermle T, Warejko JK, Shril S, Airik M, Jobst-Schwan T, Lovric S, Braun DA, Gee HY, Schapiro D, Majmundar AJ, Sadowski CE, Pabst WL, Daga A, van der Ven AT, Schmidt JM, Low BC, Gupta AB, Tripathi BK, Wong J, Campbell K, Metcalfe K, Schanze D, Niihori T, Kaito H, Nozu K, Tsukaguchi H, Tanaka R, Hamahira K, Kobayashi Y, Takizawa T, Funayama R, Nakayama K, Aoki Y, Kumagai N, Iijima K, Fehrenbach H, Kari JA, El Desoky S, Jalalah S, Bogdanovic R, Stajić N, Zappel H, Rakhmetova A, Wassmer SR, Jungraithmayr T, Strehlau J, Kumar AS, Bagga A, Soliman NA, Mane SM, Kaufman L, Lowy DR, Jairajpuri MA, Lifton RP, Pei Y, Zenker M, Kure S, Hildebrandt F.

Nat Commun. 2018 May 17;9(1):1960. doi: 10.1038/s41467-018-04193-w.

20.

Functional splicing analysis in an infantile case of atypical hemolytic uremic syndrome caused by digenic mutations in C3 and MCP genes.

Yamamura T, Nozu K, Ueda H, Fujimaru R, Hisatomi R, Yoshida Y, Kato H, Nangaku M, Miyata T, Sawai T, Minamikawa S, Kaito H, Matsuo M, Iijima K.

J Hum Genet. 2018 Jun;63(6):755-759. doi: 10.1038/s10038-018-0436-9. Epub 2018 Mar 19.

PMID:
29556035
21.

Development of ultra-deep targeted RNA sequencing for analyzing X-chromosome inactivation in female Dent disease.

Minamikawa S, Nozu K, Nozu Y, Yamamura T, Taniguchi-Ikeda M, Nakanishi K, Fujimura J, Horinouchi T, Shima Y, Nakanishi K, Hattori M, Kanda K, Tanaka R, Morisada N, Nagano C, Sakakibara N, Nagase H, Morioka I, Kaito H, Iijima K.

J Hum Genet. 2018 May;63(5):589-595. doi: 10.1038/s10038-018-0415-1. Epub 2018 Feb 19.

PMID:
29459630
22.

Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K, Kourakata H, Matsumura C, Tazoe S, Tanaka R, Yamamura T, Minamikawa S, Horinouchi T, Nakanishi K, Fujimura J, Sakakibara N, Nozu Y, Ye MJ, Kaito H, Iijima K.

Clin Exp Nephrol. 2018 Aug;22(4):881-888. doi: 10.1007/s10157-018-1534-x. Epub 2018 Jan 25.

PMID:
29372472
23.

Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome.

Yamamura T, Nozu K, Fu XJ, Nozu Y, Ye MJ, Shono A, Yamanouchi S, Minamikawa S, Morisada N, Nakanishi K, Shima Y, Yoshikawa N, Ninchoji T, Morioka I, Kaito H, Iijima K.

Kidney Int Rep. 2017 May 4;2(5):850-855. doi: 10.1016/j.ekir.2017.04.011. eCollection 2017 Sep.

24.

An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis.

Yamamura T, Nozu K, Miyoshi Y, Nakanishi K, Fujimura J, Horinouchi T, Minamikawa S, Mori N, Fujimaru R, Nakanishi K, Ninchoji T, Kaito H, Mariko TI, Morioka I, Matsuo M, Iijima K.

BMC Nephrol. 2017 Dec 4;18(1):353. doi: 10.1186/s12882-017-0774-4.

25.

Female mice lacking Pald1 exhibit endothelial cell apoptosis and emphysema.

Egaña I, Kaito H, Nitzsche A, Becker L, Ballester-Lopez C, Niaudet C, Petkova M, Liu W, Vanlandewijck M, Vernaleken A, Klopstock T, Fuchs H, Gailus-Durner V, Hrabe de Angelis M, Rask-Andersen H, Johansson HJ, Lehtiö J, He L, Yildirim AÖ, Hellström M; German Mouse Clinic Consortium.

Sci Rep. 2017 Nov 13;7(1):15453. doi: 10.1038/s41598-017-14894-9.

26.

Detection of a Splice Site Variant in a Patient with Glomerulopathy and Fibronectin Deposits.

Tsuji Y, Nozu K, Sofue T, Hara S, Nakanishi K, Yamamura T, Minamikawa S, Nozu Y, Kaito H, Fujimura J, Horinouchi T, Morisada N, Morioka I, Taniguchi-Ikeda M, Matsuo M, Iijima K.

Nephron. 2018;138(2):166-171. doi: 10.1159/000484209. Epub 2017 Nov 3.

PMID:
29131116
27.

A case of mild phenotype Alport syndrome caused by COL4A3 mutations.

Kamijo M, Kitamura M, Muta K, Uramatsu T, Obata Y, Nozu K, Kaito H, Iijima K, Mukae H, Nishino T.

CEN Case Rep. 2017 Nov;6(2):189-193. doi: 10.1007/s13730-017-0273-2. Epub 2017 Aug 30.

28.

A comparison of splicing assays to detect an intronic variant of the OCRL gene in Lowe syndrome.

Nakanishi K, Nozu K, Hiramoto R, Minamikawa S, Yamamura T, Fujimura J, Horinouchi T, Ninchoji T, Kaito H, Morisada N, Ishimori S, Nakanishi K, Morioka I, Awano H, Matsuo M, Iijima K.

Eur J Med Genet. 2017 Dec;60(12):631-634. doi: 10.1016/j.ejmg.2017.08.001. Epub 2017 Aug 9.

PMID:
28803024
29.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.

Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K; Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group.

Pediatr Nephrol. 2017 Nov;32(11):2071-2078. doi: 10.1007/s00467-017-3718-0. Epub 2017 Jun 29.

PMID:
28664242
30.

A birth of bipartite exon by intragenic deletion.

Nozu K, Iijima K, Igarashi T, Yamada S, Kralovicova J, Nozu Y, Yamamura T, Minamikawa S, Morioka I, Ninchoji T, Kaito H, Nakanishi K, Vorechovsky I.

Mol Genet Genomic Med. 2017 Mar 1;5(3):287-294. doi: 10.1002/mgg3.277. eCollection 2017 May.

31.

Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.

Nozu K, Minamikawa S, Yamada S, Oka M, Yanagita M, Morisada N, Fujinaga S, Nagano C, Gotoh Y, Takahashi E, Morishita T, Yamamura T, Ninchoji T, Kaito H, Morioka I, Nakanishi K, Vorechovsky I, Iijima K.

J Hum Genet. 2017 Jul;62(7):733-735. doi: 10.1038/jhg.2017.28. Epub 2017 Mar 9.

PMID:
28275241
32.

Diagnostic strategy for inherited hypomagnesemia.

Horinouchi T, Nozu K, Kamiyoshi N, Kamei K, Togawa H, Shima Y, Urahama Y, Yamamura T, Minamikawa S, Nakanishi K, Fujimura J, Morioka I, Ninchoji T, Kaito H, Nakanishi K, Iijima K.

Clin Exp Nephrol. 2017 Dec;21(6):1003-1010. doi: 10.1007/s10157-017-1396-7. Epub 2017 Mar 1.

PMID:
28251383
33.

Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Ninchoji T, Nozu K, Nakanishi K, Horinouchi T, Fujimura J, Yamamura T, Minamikawa S, Ishimori S, Nakanishi K, Yoshikawa N, Morioka I, Kaito H, Iijima K.

Clin Exp Nephrol. 2017 Oct;21(5):889-894. doi: 10.1007/s10157-016-1376-3. Epub 2017 Jan 10.

PMID:
28074307
34.

Female X-linked Alport syndrome with somatic mosaicism.

Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H, Hamada R, Nozu Y, Shono A, Ninchoji T, Morisada N, Ishimori S, Fujimura J, Horinouchi T, Kaito H, Nakanishi K, Morioka I, Taniguchi-Ikeda M, Iijima K.

Clin Exp Nephrol. 2017 Oct;21(5):877-883. doi: 10.1007/s10157-016-1352-y. Epub 2016 Oct 31.

PMID:
27796712
35.

Cryptic exon activation in SLC12A3 in Gitelman syndrome.

Nozu K, Nozu Y, Nakanishi K, Konomoto T, Horinouchi T, Shono A, Morisada N, Minamikawa S, Yamamura T, Fujimura J, Nakanishi K, Ninchoji T, Kaito H, Morioka I, Taniguchi-Ikeda M, Vorechovsky I, Iijima K.

J Hum Genet. 2017 Feb;62(2):335-337. doi: 10.1038/jhg.2016.129. Epub 2016 Oct 27.

PMID:
27784896
36.

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.

Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, Imafuku A, Miura K, Yamamura T, Minamikawa S, Shono A, Ninchoji T, Morioka I, Nakanishi K, Yoshikawa N, Kaito H, Iijima K.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-9. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8.

37.

Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits.

Ohtsubo H, Okada T, Nozu K, Takaoka Y, Shono A, Asanuma K, Zhang L, Nakanishi K, Taniguchi-Ikeda M, Kaito H, Iijima K, Nakamura S.

Pediatr Nephrol. 2016 Sep;31(9):1459-67. doi: 10.1007/s00467-016-3368-7. Epub 2016 Apr 7.

PMID:
27056061
38.

Combined Alport syndrome and Klinefelter syndrome.

Nishida M, Hashimoto F, Kaito H, Nozu K, Iijima K, Asada D, Hamaoka K.

Pediatr Int. 2016 Feb;58(2):152-5. doi: 10.1111/ped.12743. Epub 2015 Nov 10.

PMID:
26554353
39.

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.

Sarantopoulos J, Mita MM, Birrer MJ, Cranmer LD, Campos LT, Zhang X, Bristow P, Kaito H, Strout V, Camacho LH.

Target Oncol. 2016 Jun;11(3):317-27. doi: 10.1007/s11523-015-0394-5.

PMID:
26507836
40.

Pathogenesis of hypokalemia in autosomal dominant hypocalcemia type 1.

Kamiyoshi N, Nozu K, Urahama Y, Matsunoshita N, Yamamura T, Minamikawa S, Ninchoji T, Morisada N, Nakanishi K, Kaito H, Iijima K.

Clin Exp Nephrol. 2016 Apr;20(2):253-7. doi: 10.1007/s10157-015-1160-9. Epub 2015 Sep 1.

PMID:
26323216
41.

A novel technique of catheter placement with fibrin glue to prevent pericatheter leakage and to enable no break-in period in peritoneal dialysis.

Hisamatsu C, Maeda K, Aida Y, Yasufuku M, Ninchoji T, Kaito H, Nozu K, Iijima K, Nishijima E.

J Pediatr Urol. 2015 Oct;11(5):299-300. doi: 10.1016/j.jpurol.2015.07.005. Epub 2015 Aug 7.

PMID:
26320395
42.

Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.

Fu XJ, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K, Yoshikawa N, Ohtsubo H, Matsunoshita N, Kamiyoshi N, Matsumura C, Takagi N, Maekawa K, Taniguchi-Ikeda M, Iijima K.

Eur J Hum Genet. 2016 Mar;24(3):387-91. doi: 10.1038/ejhg.2015.113. Epub 2015 May 27.

43.

Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics.

Matsunoshita N, Nozu K, Shono A, Nozu Y, Fu XJ, Morisada N, Kamiyoshi N, Ohtsubo H, Ninchoji T, Minamikawa S, Yamamura T, Nakanishi K, Yoshikawa N, Shima Y, Kaito H, Iijima K.

Genet Med. 2016 Feb;18(2):180-8. doi: 10.1038/gim.2015.56. Epub 2015 Apr 16.

PMID:
25880437
44.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Kaku Y, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ishikura K, Iijima K; Japanese Society for Pediatric Nephrology.

Clin Exp Nephrol. 2015 Feb;19(1):34-53. doi: 10.1007/s10157-014-1031-9. No abstract available.

PMID:
25653047
45.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.

Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Kaku Y, Iijima K; Japanese Society for Pediatric Nephrology; Japanese Society for Pediatric Nephrology.

Clin Exp Nephrol. 2015 Feb;19(1):6-33. doi: 10.1007/s10157-014-1030-x. No abstract available.

PMID:
25653046
46.

Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY.

Nozu K, Iijima K, Ohtsuka Y, Fu XJ, Kaito H, Nakanishi K, Vorechovsky I.

Mol Genet Genomic Med. 2014 Sep;2(5):451-3. doi: 10.1002/mgg3.89. Epub 2014 May 28.

47.

X-linked Alport syndrome caused by splicing mutations in COL4A5.

Nozu K, Vorechovsky I, Kaito H, Fu XJ, Nakanishi K, Hashimura Y, Hashimoto F, Kamei K, Ito S, Kaku Y, Imasawa T, Ushijima K, Shimizu J, Makita Y, Konomoto T, Yoshikawa N, Iijima K.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1958-64. doi: 10.2215/CJN.04140414. Epub 2014 Sep 2.

48.

Renal biopsy criterion in idiopathic nephrotic syndrome with microscopic hematuria at onset.

Hama T, Nakanishi K, Shima Y, Sato M, Mukaiyama H, Togawa H, Hamahira K, Tanaka R, Kaito H, Nozu K, Iijima K, Yoshikawa N.

Pediatr Nephrol. 2015 Mar;30(3):445-50. doi: 10.1007/s00467-014-2946-9. Epub 2014 Aug 27.

PMID:
25159721
49.

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.

Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children.

Kidney Int. 2015 Jan;87(1):225-32. doi: 10.1038/ki.2014.260. Epub 2014 Jul 23.

50.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.

Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.

Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22.

PMID:
24965823

Supplemental Content

Support Center